A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.
Public ClinicalTrials.gov record NCT05296629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Parallel-Group, Active and Placebo Controlled Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Extended Release Capsules for the Treatment of Inflammatory Lesions of Rosacea Over 16 Weeks.
Study identification
- NCT ID
- NCT05296629
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Journey Medical Corporation
- Industry
- Enrollment
- 323 participants
Conditions and interventions
Conditions
Interventions
- DFD-29 Drug
- Doxycycline Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 13, 2022
- Primary completion
- Jun 29, 2023
- Completion
- Jun 29, 2023
- Last update posted
- Dec 2, 2024
2022 – 2023
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Trial Site 05 | Rogers | Arkansas | 72758 | — |
| Clinical Trial Site 10 | Cerritos | California | 90703 | — |
| Clinical Trial Site 03 | Fremont | California | 94538 | — |
| Clinical Trial Site 25 | San Diego | California | 92123 | — |
| Clinical Trial Site 29 | San Diego | California | 92123 | — |
| Clinical Trial Site 11 | Clearwater | Florida | 33761 | — |
| Clinical Trial Site 08 | Coral Gables | Florida | 33134 | — |
| Clinical Trial Site 22 | Coral Gables | Florida | 33134 | — |
| Clinical Trial Site 02 | Indianapolis | Indiana | 46250 | — |
| Clinical Trial Site 27 | Overland Park | Kansas | 66210 | — |
| Clinical Trial Site 09 | Brighton | Massachusetts | 02135 | — |
| Clinical Trial Site 18 | Ann Arbor | Michigan | 48103 | — |
| Clinical Trial Site 28 | Warren | Michigan | 48088 | — |
| Clinical Trial Site 21 | New Brighton | Minnesota | 55112 | — |
| Clinical Trial Site 15 | Las Vegas | Nevada | 89148 | — |
| Clinical Trial Site 24 | New York | New York | 10019 | — |
| Clinical Trial Site 17 | High Point | North Carolina | 27262 | — |
| Clinical Trial Site 04 | Wilmington | North Carolina | 28405 | — |
| Clinical Trial Site 06 | Beachwood | Ohio | 44122 | — |
| Clinical Trial Site 01 | Sugarloaf | Pennsylvania | 18249 | — |
| Clinical Trial Site 19 | East Greenwich | Rhode Island | 02818 | — |
| Clinical Trial Site 23 | Nashville | Tennessee | 37215 | — |
| Clinical Trial Site 20 | College Station | Texas | 77845 | — |
| Clinical Trial Site 13 | Houston | Texas | 77055 | — |
| Clinical Trial Site 07 | Plano | Texas | 75093 | — |
| Clinical Trial Site 26 | San Antonio | Texas | 78213 | — |
| Clinical Trial Site 12 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05296629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 2, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05296629 live on ClinicalTrials.gov.